Advertisement
Lupin Limited

Lupin Limited Fundamental Analysis

LUPIN.BOBSE
HealthcareDrug Manufacturers - Specialty & Generic
2356.55
17.10(0.73%)
Indian Market is Open · 09:28
Advertisement

Lupin Limited Fundamental Analysis

Lupin Limited (LUPIN.BO) shows moderate financial fundamentals with a PE ratio of 20.19, profit margin of 19.12%, and ROE of 27.86%. The company generates $278.9B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

ROE27.86%
Operating Margin32.06%
PEG Ratio0.32
Current Ratio1.90

Areas of Concern

No major concerns flagged.
We analyze LUPIN.BO's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 94.9/100 based on profitability, valuation, growth, and balance sheet metrics. The A grade reflects excellent fundamentals and strong overall stability.

Fundamental Health Score

A
94.9/100

We analyze LUPIN.BO's fundamental strength across five key dimensions:

Efficiency Score

Excellent

LUPIN.BO demonstrates superior asset utilization.

ROA > 10%
13.90%

Valuation Score

Excellent

LUPIN.BO trades at attractive valuation levels.

PE < 25
20.19
PEG Ratio < 2
0.32

Growth Score

Moderate

LUPIN.BO shows steady but slowing expansion.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

LUPIN.BO maintains a strong and stable balance sheet.

Debt/Equity < 1
0.29
Current Ratio > 1
1.90

Profitability Score

Excellent

LUPIN.BO achieves industry-leading margins.

ROE > 15%
27.86%
Net Margin ≥ 15%
19.12%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is LUPIN.BO Expensive or Cheap?

P/E Ratio

LUPIN.BO trades at 20.19 times earnings. This indicates a fair valuation.

20.19

PEG Ratio

When adjusting for growth, LUPIN.BO's PEG of 0.32 indicates potential undervaluation.

0.32

Price to Book

The market values Lupin Limited at 4.80 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

4.80

EV/EBITDA

Enterprise value stands at 12.62 times EBITDA. This signals the market has high growth expectations.

12.62

How Well Does LUPIN.BO Make Money?

Net Profit Margin

For every $100 in sales, Lupin Limited keeps $19.12 as profit after all expenses.

19.12%

Operating Margin

Core operations generate 32.06 in profit for every $100 in revenue, before interest and taxes.

32.06%

ROE

Management delivers $27.86 in profit for every $100 of shareholder equity.

27.86%

ROA

Lupin Limited generates $13.90 in profit for every $100 in assets, demonstrating efficient asset deployment.

13.90%

Following the Money - Real Cash Generation

Operating Cash Flow

Lupin Limited produces operating cash flow of $29.03B, showing steady but balanced cash generation.

$29.03B

Free Cash Flow

Lupin Limited produces free cash flow of $23.29B, offering steady but limited capital for shareholder returns and expansion.

$23.29B

FCF Per Share

Each share generates $50.97 in free cash annually.

$50.97

FCF Yield

LUPIN.BO converts 2.16% of its market value into free cash.

2.16%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

20.19

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.32

vs 25 benchmark

P/B Ratio

Price to book value ratio

4.80

vs 25 benchmark

P/S Ratio

Price to sales ratio

3.87

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.29

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.90

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.28

vs 25 benchmark

ROA

Return on assets percentage

0.14

vs 25 benchmark

ROCE

Return on capital employed

0.35

vs 25 benchmark

How LUPIN.BO Stacks Against Its Sector Peers

MetricLUPIN.BO ValueSector AveragePerformance
P/E Ratio20.1933.92 Better (Cheaper)
ROE27.86%393.00% Weak
Net Margin19.12%-41456.00% (disorted) Strong
Debt/Equity0.290.80 Strong (Low Leverage)
Current Ratio1.904.57 Neutral
ROA13.90%-293.00% (disorted) Strong

LUPIN.BO outperforms its industry in 4 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Lupin Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ